Product Code: MD 2133
The disposable medical device sensors market is projected to reach USD 16.13 billion by 2031 from USD 11.86 billion in 2026, at a CAGR of 6.4% during the forecast period.
| Scope of the Report |
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | By product, type, application, end user, and region |
| Regions covered | North America, Europe, APAC, LATAM, MEA |
The disposable medical device sensors market is largely driven by the increasing prevalence of chronic diseases, infectious diseases, and lifestyle-related disorders, which has created a growing demand for accurate, rapid, and continuous monitoring solutions. The rising adoption of patient monitoring systems, point-of-care diagnostics, wearable healthcare devices, and home-based medical care solutions has significantly increased the demand for disposable sensor technologies. Advancements in disposable sensor technologies, including biosensors, wearable sensors, strip sensors, and miniaturized monitoring devices, have improved diagnostic accuracy, reliability, and ease of use. These innovations have enabled broader applications in glucose monitoring, infectious disease testing, cardiac monitoring, respiratory care, and other clinical and home healthcare settings. Furthermore, the growing emphasis on infection prevention, reduced risk of cross-contamination, and the advantages of single-use medical devices have strengthened the adoption of disposable sensors among healthcare providers.

Additionally, increasing awareness among patients and healthcare professionals regarding early disease detection, remote patient monitoring, and personalized healthcare solutions, along with the expansion of healthcare infrastructure and diagnostic facilities, has positively influenced market growth. The combination of rising healthcare needs, technological advancements, and increasing adoption of digital and decentralized healthcare solutions is driving the global demand for disposable medical device sensors.
"By type, biosensors held the largest market share in the disposable medical device sensors market."
By type, biosensors held the largest market share in the disposable medical device sensors market. This dominance can be attributed to the widespread adoption of biosensors across various diagnostic and monitoring applications, including glucose monitoring, infectious disease testing, pregnancy testing, drug and alcohol screening, and continuous glucose monitoring (CGM) systems. Biosensors play a critical role in enabling rapid, accurate, and minimally invasive detection of biological parameters, making them highly valuable in both clinical and home healthcare settings. The increasing prevalence of diabetes, infectious diseases, and other chronic conditions has further accelerated the demand for biosensor-based disposable medical devices. Additionally, advancements in biosensor technologies, including improved sensitivity, miniaturization, and integration with digital health platforms, have enhanced their usability and expanded their applications across point-of-care diagnostics and remote patient monitoring. These factors have contributed to the leading position of the biosensors segment in the disposable medical device sensors market.
"By type, strip sensors are expected to hold the largest share in the disposable medical device sensors market."
By type, strip sensors are expected to hold the largest share in the disposable medical device sensors market. This dominance is attributed to their extensive use in diagnostic applications, particularly glucose monitoring, infectious disease testing, pregnancy testing, and other rapid point-of-care testing procedures. Strip sensors offer several advantages, including affordability, ease of use, portability, quick turnaround time, and minimal sample requirements, making them highly suitable for both clinical and home-based healthcare settings. The increasing global prevalence of diabetes and infectious diseases has significantly contributed to the rising demand for glucose test strips and diagnostic test strips. Additionally, the growing adoption of self-monitoring devices, decentralized diagnostic solutions, and home healthcare technologies, along with continuous advancements in sensor accuracy and performance, is expected to further support the growth and leading position of the strip sensors segment in the disposable medical device sensors market.
"The US is expected to grow at the highest CAGR in the North American disposable medical device sensors market during the forecast period."
The US is expected to grow at the highest CAGR in the North American disposable medical device sensors market during the forecast period. This growth is driven by several key factors, including the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions, which are creating a strong demand for continuous monitoring and diagnostic solutions. The country's advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong presence of leading medical device manufacturers are further supporting market expansion. Additionally, the growing adoption of wearable medical devices, remote patient monitoring systems, and point-of-care diagnostic solutions is accelerating the demand for disposable sensors across hospitals, clinics, and home healthcare settings. Furthermore, increasing awareness regarding infection prevention, the benefits of single-use medical devices, and favorable reimbursement policies are contributing to the rapid adoption of disposable medical device sensors in the US market. Collectively, these factors position the US as the leading and fastest-growing market for disposable medical device sensors in North America.
A breakdown of the primary participants (on the supply side) for the disposable medical device sensors market referenced in this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
- By Designation: C-level Executives (45%), Directors (35%), and Others (20%)
- By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
The prominent players operating in the disposable medical device sensors market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), and GE HealthCare Technologies Inc. (US).
Research Coverage:
The report provides an analysis of the disposable medical device sensors market, focusing on estimating its size and future growth potential across segments such as product, application, type, end user, and region. Additionally, the report features a competitive analysis of key players in the market, including their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report provides valuable insights for both market leaders and new entrants in the disposable medical device sensors market, offering the most accurate revenue estimates. It helps stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, giving stakeholders a comprehensive understanding of current market trends.
This report provides insights into the following pointers:
- Analysis of key drivers (Rising concerns over hospital-acquired infections and contamination, Increasing incidence of target conditions, Growing demand for home-based medical care devices, Significant Technological Advancements in Disposable Medical Sensor Technologies), restraints (Stringent Regulatory Requirements, Product Validation, and High Compliance Costs, Environmental Concerns and Increasing Regulatory Pressure on Single-Use Medical Waste), opportunities (Expanding Healthcare Infrastructure and Rising Disease Burden in Emerging Economies, Expansion of Remote Patient Monitoring (RPM) and Home Healthcare), and challenges (Vulnerability of connected medical devices in terms of data leakages).
- Market Penetration: It includes extensive information on the products offered by the major players in the global disposable medical device sensors market. The report includes various segments, such as product, type, application, end user, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global disposable medical device sensors market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global disposable medical device sensors market.
- Competitive Assessment: A comprehensive assessment of market shares, growth strategies, product offerings, and capabilities of key competitors in the global disposable medical device sensors market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONS CONSIDERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 KEY STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND DEVELOPMENTS
- 2.2 DISRUPTIVE TRENDS SHAPING MARKET
- 2.3 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
- 2.4 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 DISPOSABLE MEDICAL DEVICE SENSORS MARKET OVERVIEW
- 3.2 ASIA PACIFIC: DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY TYPE AND COUNTRY, (2025)
- 3.3 DISPOSABLE MEDICAL DEVICE SENSORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, REGIONAL MIX, 2024-2031
- 3.5 DISPOSABLE MEDICAL DEVICE SENSORS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising concerns over hospital-acquired infections and contamination
- 4.2.1.2 Increasing incidence of target conditions
- 4.2.1.3 Growing demand for home-based medical care devices
- 4.2.1.4 Advancements in sensor technologies
- 4.2.2 RESTRAINTS
- 4.2.2.1 Stringent regulatory requirements, product validation, and high compliance costs
- 4.2.2.2 Environmental concerns and increasing regulatory pressure on single-use medical waste
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expanding healthcare infrastructure and rising disease burden in emerging economies
- 4.2.3.2 Expansion of remote patient monitoring and home healthcare
- 4.2.4 CHALLENGES
- 4.2.4.1 Vulnerability of connected medical devices in terms of data leakages
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER- 1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN DISPOSABLE MEDICAL DEVICE SENSORS MARKET
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE, BY PRODUCT, 2023-2025
- 5.6.2 AVERAGE SELLING PRICE, BY REGION, 2023-2025
- 5.6.3 AVERAGE SELLING PRICE, BY KEY PLAYER, 2023-2025
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT SCENARIO (HS CODE 901819)
- 5.7.2 EXPORT SCENARIO (HS CODE 901819)
- 5.8 KEY CONFERENCES & EVENTS DURING 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 CASE STUDY ANALYSIS
- 5.12 IMPACT OF US TARIFFS-DISPOSABLE MEDICAL DEVICE SENSORS MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 KEY TARIFF RATES
- 5.12.3 PRICE IMPACT ANALYSIS
- 5.12.3.1 US
- 5.12.3.2 Europe
- 5.12.3.3 Asia Pacific
- 5.12.3.4 Impact on end-user industries
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 AI-ENABLED WEARABLE BIOSENSORS & INTELLIGENT PATIENT MONITORING
- 6.1.2 FLEXIBLE ELECTRONICS & NEXT-GENERATION PRINTED BIOSENSORS
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 INTERNET OF MEDICAL THINGS (IOMT) & REMOTE PATIENT MONITORING PLATFORMS
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 MEMS & ADVANCED SEMICONDUCTOR TECHNOLOGIES
- 6.3.2 CLOUD COMPUTING, ARTIFICIAL INTELLIGENCE, AND DIGITAL HEALTH PLATFORMS
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.4.1 SHORT-TERM |RECENT TECHNOLOGIES| FOUNDATION & EARLY COMMERCIALIZATION
- 6.4.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
- 6.4.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
- 6.5 PATENT ANALYSIS
- 6.5.1 PATENT PUBLICATION TRENDS FOR DISPOSABLE MEDICAL SENSORS
- 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 6.5.3 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DISPOSABLE MEDICAL SENSORS PATENTS (JANUARY 2015-DECEMBER 2025)
- 6.5.4 TOP APPLICANT COUNTRIES/REGIONS PATENTS FOR DISPOSABLE MEDICAL SENSORS (JANUARY 2015-DECEMBER 2025)
- 6.6 IMPACT OF AI/GEN AI ON DISPOSABLE MEDICAL SENSORS MARKET
- 6.6.1 TOP USE CASES AND MARKET POTENTIAL
- 6.6.2 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
- 6.6.3 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN DISPOSABLE MEDICAL SENSORS MARKET
- 6.7 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
- 6.7.1 ABBOTT: REVOLUTIONIZING CONTINUOUS GLUCOSE MONITORING WITH FREESTYLE LIBRE
- 6.7.2 DEXCOM: AI-ENABLED CONTINUOUS GLUCOSE MONITORING FOR PERSONALIZED DIABETES CARE
- 6.7.3 ICS COOL ENERGY: MASIMO REDUCES CROSS-CONTAMINATION AND IMPROVES INFECTION PREVENTION WITH LNCS SENSORS
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 US
- 7.1.2 EUROPEAN UNION
- 7.1.3 CHINA
- 7.1.4 LATIN AMERICA
- 7.1.5 MIDDLE EAST & AFRICA
- 7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.3 SUSTAINABILITY INITIATIVES
- 7.3.1 ENVIRONMENTAL SUSTAINABILITY IN DISPOSABLE MEDICAL SENSOR SYSTEMS
- 7.3.2 SUSTAINABLE MANUFACTURING & CIRCULAR ECONOMY INITIATIVES
- 7.3.3 DIGITAL HEALTH, REMOTE PATIENT MONITORING & SUSTAINABILITY
- 7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.2.1 INFLUENCE OF KEY STAKEHOLDERS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY PRODUCT
- 9.1 INTRODUCTION
- 9.2 BIOSENSORS
- 9.2.1 INCREASING NUMBER OF TARGET DISEASES AND RISING HEALTH AWARENESS TO PROPEL MARKET GROWTH
- 9.3 PRESSURE SENSORS
- 9.3.1 TECHNOLOGICAL ADVANCEMENTS IN PRESSURE SENSORS TO BOOST MARKET GROWTH
- 9.4 TEMPERATURE SENSORS
- 9.4.1 COST-EFFECTIVENESS OF TEMPERATURE SENSORS TO DRIVE DEMAND
- 9.5 ACCELEROMETERS
- 9.5.1 RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
- 9.6 IMAGE SENSORS
- 9.6.1 INNOVATIONS IN IMAGE SENSORS TO BOOST MARKET GROWTH
- 9.7 OTHER SENSORS
10 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY TYPE
- 10.1 INTRODUCTION
- 10.2 STRIP SENSORS
- 10.2.1 RISING NUMBER OF DIABETIC PATIENTS TO SUPPORT MARKET GROWTH
- 10.3 WEARABLE SENSORS
- 10.3.1 TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN WEARABLE DEVICES TO BOOST MARKET GROWTH
- 10.4 INVASIVE SENSORS
- 10.4.1 INCREASED PREFERENCE FOR WEARABLE DEVICES MAY NEGATIVELY IMPACT MARKET FOR INVASIVE SENSORS
- 10.5 INGESTIBLE SENSORS
- 10.5.1 TECHNOLOGICAL ADVANCEMENTS IN INGESTIBLE SENSORS TO DRIVE END-USER DEMAND
11 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 DIAGNOSTIC TESTING
- 11.2.1 BLOOD GLUCOSE TEST STRIP SENSORS
- 11.2.1.1 High prevalence of diabetes to drive market growth
- 11.2.2 PREGNANCY TEST STRIP SENSORS
- 11.2.2.1 Increasing demand for testing strips for home use to drive market growth
- 11.2.3 INFECTIOUS DISEASE TEST STRIP SENSORS
- 11.2.3.1 High burden of infectious diseases to propel market growth
- 11.2.4 DRUG & ALCOHOL TEST STRIP SENSORS
- 11.2.4.1 Market growth may be restrained as most tests are not available over the counter
- 11.3 PATIENT MONITORING
- 11.3.1 CARDIAC MONITORS
- 11.3.1.1 Sedentary lifestyles causing an increase in cardiovascular disease prevalence-a key factor driving market growth
- 11.3.2 PULSE OXIMETERS
- 11.3.2.1 Growing need for continuous oxygen monitoring to boost demand for pulse oximeters
- 11.3.3 CONTINUOUS BLOOD PRESSURE MONITORS
- 11.3.3.1 Increasing prevalence of hypertension to drive market growth
- 11.3.4 CGM DEVICES
- 11.3.4.1 Increased preference for home-use devices to drive growth in this market segment
- 11.3.5 SMART PILLS
- 11.3.5.1 Ease of use and reduced expenditure associated with smart pills to drive market growth
- 11.3.6 OTHER PATIENT MONITORING DEVICES
- 11.4 THERAPEUTICS
- 11.4.1 DIALYSIS DEVICE SENSORS
- 11.4.1.1 Rising urology disorders to drive market growth
- 11.4.2 CARDIAC CATHETER SENSORS
- 11.4.2.1 High prevalence of cardiac diseases to boost market growth
- 11.4.3 INSULIN PUMP SENSORS
- 11.4.3.1 High cost of insulin pumps can limit market growth
- 11.5 IMAGING
- 11.5.1 CAPSULE ENDOSCOPE SENSORS
- 11.5.1.1 Capsule endoscopes are easy to use and cost-effective-key factors driving market growth
- 11.5.2 DISPOSABLE ENDOSCOPE SENSORS
- 11.5.2.1 Growing preference for single-use endoscopes and rising endoscopic procedures to drive market growth
12 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 HOSPITALS & CLINICS
- 12.2.1 INCREASING PATIENT MONITORING NEEDS AND INFECTION CONTROL MEASURES SUPPORT THE MARKET GROWTH
- 12.3 HOME CARE SETTINGS
- 12.3.1 RISING ADOPTION OF REMOTE PATIENT MONITORING AND HOME-BASED HEALTHCARE TO BOOST THE MARKET GROWTH
- 12.4 DIAGNOSTIC LABS
- 12.4.1 GROWING DEMAND FOR ACCURATE DIAGNOSTICS AND POCT ACCELERATES ADOPTION
- 12.5 OTHER END USERS
13 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY REGION
- 13.1 INTRODUCTION
- 13.2 NORTH AMERICA
- 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 13.2.2 US
- 13.2.2.1 Increasing funding and investments in medical sensors to drive market growth
- 13.2.3 CANADA
- 13.2.3.1 High prevalence of HAIs is a major factor driving the demand for disposable medical device sensors in Canada
- 13.3 EUROPE
- 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 13.3.2 GERMANY
- 13.3.2.1 Increasing demand for safer diagnostic devices to drive market growth in Germany
- 13.3.3 FRANCE
- 13.3.3.1 Growing geriatric population to increase demand for disposable medical device sensors
- 13.3.4 UK
- 13.3.4.1 Rising incidence of target diseases to support market growth
- 13.3.5 ITALY
- 13.3.5.1 Rising age-related disorders to aid market growth in Italy
- 13.3.6 SPAIN
- 13.3.6.1 Aging population and healthcare innovation to support market growth in Spain
- 13.3.7 REST OF EUROPE
- 13.4 ASIA PACIFIC
- 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 13.4.2 CHINA
- 13.4.2.1 Government initiatives to develop innovative healthcare products to propel market growth
- 13.4.3 JAPAN
- 13.4.3.1 High prevalence of HAIs to create demand for disposable medical device sensors
- 13.4.4 INDIA
- 13.4.4.1 High burden of chronic diseases to support market growth
- 13.4.5 AUSTRALIA
- 13.4.5.1 High burden of chronic diseases to support market growth
- 13.4.6 SOUTH KOREA
- 13.4.6.1 High burden of chronic diseases to support market growth
- 13.4.7 REST OF ASIA PACIFIC
- 13.5 LATIN AMERICA
- 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 13.5.2 BRAZIL
- 13.5.2.1 Growing healthcare burden and aging population to support market growth
- 13.5.3 MEXICO
- 13.5.3.1 Rising diabetes burden and healthcare demand to support market growth
- 13.5.4 REST OF LATIN AMERICA
- 13.6 MIDDLE EAST & AFRICA
- 13.6.1 HIGH PREVALENCE OF INFECTIOUS DISEASES TO BOOST MARKET GROWTH
- 13.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 13.7 GCC COUNTRIES
- 13.7.1 HEALTHCARE MODERNIZATION AND HIGH DIABETES BURDEN TO DRIVE THE MARKET GROWTH
- 13.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
14 COMPETITIVE LANDSCAPE
- 14.1 INTRODUCTION
- 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE MEDICAL DEVICE SENSORS MARKET
- 14.3 REVENUE ANALYSIS, 2021-2025
- 14.4 MARKET SHARE ANALYSIS (2025)
- 14.5 COMPANY VALUATION AND FINANCIAL METRICS
- 14.5.1 COMPANY VALUATION
- 14.5.2 FINANCIAL METRICS
- 14.5.3 BRAND/PRODUCT COMPARISON
- 14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 14.6.1 STARS
- 14.6.2 EMERGING LEADERS
- 14.6.3 PERVASIVE PLAYERS
- 14.6.4 PARTICIPANTS
- 14.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 14.6.5.1 Company footprint
- 14.6.5.2 Region footprint
- 14.6.5.3 Type footprint
- 14.6.5.4 Application footprint
- 14.6.5.5 Product footprint
- 14.6.5.6 End-user footprint
- 14.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2025)
- 14.7.1 PROGRESSIVE COMPANIES
- 14.7.2 RESPONSIVE COMPANIES
- 14.7.3 DYNAMIC COMPANIES
- 14.7.4 STARTING BLOCKS
- 14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 14.7.5.1 Detailed list of key startups/SMEs
- 14.7.5.2 Competitive benchmarking of key startups/SMEs
- 14.8 R&D EXPENDITURE OF KEY PLAYERS (DISPOSABLE MEDICAL DEVICE SENSORS MARKET)
- 14.9 COMPETITIVE SCENARIO
- 14.9.1 PRODUCT LAUNCHES & APPROVALS
- 14.9.2 DEALS
- 14.9.3 EXPANSIONS
15 COMPANY PROFILES
- 15.1 INTRODUCTION
- 15.2 KEY PLAYERS
- 15.2.1 ABBOTT LABORATORIES
- 15.2.1.1 Business overview
- 15.2.1.2 Products offered
- 15.2.1.3 Recent developments
- 15.2.1.3.1 Product approvals
- 15.2.1.3.2 Deals
- 15.2.1.3.3 Expansions
- 15.2.1.3.4 Other developments
- 15.2.1.4 MnM view
- 15.2.1.4.1 Right to win
- 15.2.1.4.2 Strategic choices made
- 15.2.1.4.3 Weaknesses and competitive threats
- 15.2.2 F. HOFFMANN-LA ROCHE LTD.
- 15.2.2.1 Business overview
- 15.2.2.2 Products offered
- 15.2.2.3 Recent developments
- 15.2.2.3.1 Product launches & approvals
- 15.2.2.3.2 Deals
- 15.2.2.3.3 Expansions
- 15.2.2.4 MnM view
- 15.2.2.4.1 Right to win
- 15.2.2.4.2 Strategic choices made
- 15.2.2.4.3 Weaknesses and competitive threats
- 15.2.3 MEDTRONIC PLC
- 15.2.3.1 Business Overview
- 15.2.3.2 Products offered
- 15.2.3.3 Recent developments
- 15.2.3.3.1 Product launches & approvals
- 15.2.3.3.2 Deals
- 15.2.3.3.3 Expansions
- 15.2.3.4 MnM view
- 15.2.3.4.1 Right to win
- 15.2.3.4.2 Strategic choices made
- 15.2.3.4.3 Weaknesses and competitive threats
- 15.2.4 LIFESCAN IP HOLDINGS, LLC
- 15.2.4.1 Business overview
- 15.2.4.2 Products offered
- 15.2.4.3 Recent developments
- 15.2.4.4 MnM view
- 15.2.4.4.1 Right to win
- 15.2.4.4.2 Strategic choices made
- 15.2.4.4.3 Weaknesses and competitive threats
- 15.2.5 TEXAS INSTRUMENTS
- 15.2.5.1 Business overview
- 15.2.5.2 Products offered
- 15.2.5.3 Recent developments
- 15.2.5.4 MnM view
- 15.2.5.4.1 Right to win
- 15.2.5.4.2 Strategic choices made
- 15.2.5.4.3 Weaknesses and competitive threats
- 15.2.6 TE CONNECTIVITY
- 15.2.6.1 Business overview
- 15.2.6.2 Products offered
- 15.2.6.3 Recent developments
- 15.2.6.3.1 Product launches
- 15.2.6.3.2 Deals
- 15.2.6.3.3 Expansions
- 15.2.7 HONEYWELL INTERNATIONAL, INC.
- 15.2.7.1 Business overview
- 15.2.7.2 Products offered
- 15.2.7.3 Recent developments
- 15.2.7.3.1 Product launches
- 15.2.7.3.2 Deals
- 15.2.8 NXP SEMICONDUCTORS N.V.
- 15.2.8.1 Business overview
- 15.2.8.2 Products offered
- 15.2.9 STMICROELECTRONICS N.V.
- 15.2.9.1 Business overview
- 15.2.9.2 Products offered
- 15.2.9.3 Recent developments
- 15.2.9.3.1 Product launches
- 15.2.9.3.2 Deals
- 15.2.10 ANALOG DEVICES, INC.
- 15.2.10.1 Business overview
- 15.2.10.2 Products offered
- 15.2.11 ICU MEDICAL, INC. (SMITHS MEDICAL)
- 15.2.11.1 Business overview
- 15.2.11.2 Products offered
- 15.2.11.3 Recent developments
- 15.2.12 KONINKLIJKE PHILIPS N.V.
- 15.2.12.1 Business overview
- 15.2.12.2 Products offered
- 15.2.12.3 Recent developments
- 15.2.12.3.1 Deals
- 15.2.12.3.2 Expansions
- 15.2.13 GE HEALTHCARE
- 15.2.13.1 Business overview
- 15.2.13.2 Products offered
- 15.2.14 OMNIVISION
- 15.2.14.1 Business overview
- 15.2.14.2 Products offered
- 15.2.14.3 Recent developments
- 15.2.14.3.1 Product launches
- 15.2.15 LIFESIGNALS
- 15.2.15.1 Business overview
- 15.2.15.2 Products offered
- 15.2.15.3 Recent developments
- 15.2.15.3.1 Product approvals
- 15.3 OTHER PLAYERS
- 15.3.1 SENSIRION AG
- 15.3.2 AMPHENOL CORPORATION
- 15.3.3 NUOVA GMBH
- 15.3.4 STARBOARD MEDICAL, INC.
- 15.3.5 SHENZHEN MED-LINK ELECTRONICS TECH CO., LTD.
- 15.3.6 MEDICAL SENSORS INDIA PVT. LTD.
- 15.3.7 GENTAG, INC.
- 15.3.8 VITALCONNECT, INC.
- 15.3.9 CONMED CORPORATION
- 15.3.10 SSI ELECTRONICS
16 RESEARCH METHODOLOGY
- 16.1 RESEARCH DATA
- 16.1.1 SECONDARY DATA
- 16.1.1.1 Key data from secondary sources
- 16.1.2 PRIMARY DATA
- 16.1.2.1 Key data from primary sources
- 16.1.2.2 Key industry insights
- 16.2 MARKET SIZE ESTIMATION
- 16.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 16.4 MARKET SHARE ESTIMATION
- 16.5 RESEARCH ASSUMPTIONS
- 16.6 RESEARCH LIMITATIONS
- 16.6.1 SCOPE-RELATED LIMITATIONS
- 16.6.2 METHODOLOGY-RELATED LIMITATIONS
- 16.7 RISK ASSESSMENT
17 APPENDIX
- 17.1 DISCUSSION GUIDE
- 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 17.3 CUSTOMIZATION OPTIONS
- 17.4 RELATED REPORTS
- 17.5 AUTHOR DETAILS